Robert Sebra

245 papers receiving 17.8k citations

Robert Sebra's Hit Papers

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial 2023 · 100 citations
1000+6+12Years since publication50010001.5k2.0k2.5k

Peers

Robert Sebra
Comparison fields: 5 of 194
  • Molecular Medicine 1.5k
  • Endocrinology 1.1k
  • Infectious Diseases 2.1k
  • Molecular Biology 7.9k
  • Cancer Research 1.5k
Replace Mark J. Walker with:
Mark J. Walker Australia
Jeffery S. Cox United States
Guo-Ping Zhao China
Vojo P. Deretic United States
John Hunter Brumell Canada
Thomas F. Meyer Germany
Kerwyn Casey Huang United States
Serge Mostowy United Kingdom
Karen L. Oliver Australia
Xiang Qin United States
Robert Sebra relative to Mark J. Walker Australia Mark J. Walker's profile →
Citations per field
00.5×1.5×2×2.4×
Mark J. Walker · 1×
Citations per year

Countries citing papers authored by Robert Sebra

Since Specialization
Citations

This map shows the geographic impact of Robert Sebra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Sebra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Sebra more than expected).

Fields of papers citing papers by Robert Sebra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Sebra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Sebra. The network helps show where Robert Sebra may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Sebra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Sebra Line = papers co-authored together Robert Sebra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Real-Time DNA Sequencing from Single Polymerase Molecules
Hit paper breakdown →
20082799
2
An integrated map of structural variation in 2,504 human genomes
Hit paper breakdown →
20151624
3
Negative feedback control of neuronal activity by microglia
Hit paper breakdown →
2020723
4
Origins of the E. coli Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
Hit paper breakdown →
2011683
5
Mapping the human genetic architecture of COVID-19
Hit paper breakdown →
2021641
6
Comparative analysis of tandem repeats from hundreds of species reveals unique insights into centromere evolution
Hit paper breakdown →
2013382
7 2015348
8 2015329
9 2020286
10 2016273
11 2020263
12 2017256
13 2016232
14
Whole-genome sequencing reveals host factors underlying critical COVID-19
Hit paper breakdown →
2022228
15
Dietary fructose improves intestinal cell survival and nutrient absorption
Hit paper breakdown →
2021224
16 2019224
17 2021198
18 2021184
19 2015155
20 2020154

About Robert Sebra

Robert Sebra is a scholar working on Molecular Medicine, Infectious Diseases, Molecular Biology, Cancer Research and Endocrinology, having authored 254 papers that have together received 18.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (23 papers), Cancer Genomics and Diagnostics (19 papers), Single-cell and spatial transcriptomics (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers), SARS-CoV-2 and COVID-19 Research (15 papers), Genomics and Phylogenetic Studies (14 papers), Genetic Associations and Epidemiology (13 papers) and RNA Research and Splicing (11 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Endocrinology (1.1k citations), Infectious Diseases (2.1k citations), Molecular Biology (7.9k citations) and Cancer Research (1.5k citations). Robert Sebra has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Gintaras Y. Deikus, Andrew Kasarskis, Kristi S. Anseth, Christopher N. Bowman, Derrick W. Crook, Eric E. Schadt, Nicole E Stoesser, Anna E. Sheppard, Tim Peto and Peter E. Warburton. Their work appears in journals such as Nature Communications, Antimicrobial Agents and Chemotherapy, Science, Nature and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact